The Drugs for Neglected Diseases initiative (DNDi) was created in response to the frustration of clinicians and the desperation of patients faced with medicines that were ineffective, unavailable, and unaffordable. Nearly two decades later, we have grown into a network of more than 200 partner institutions that spans the globe and together, we have delivered nine new treatments that have saved millions of lives.
This is the time to look ahead. On 30 March 2021, DNDi officially launched its 2021-2028 Strategic Plan following consultations with partners. The plan charts an eight-year journey for our work with neglected patients. We aim to deliver 25 new treatments in our first 25 years.
To achieve elimination and control of neglected diseases, the critical role of partnerships and commitment by African leaders in innovation and open science cannot be understated.
The DNDi Africa regional office hosted a virtual discussion to unpack the role of African leadership in innovation for neglected tropical diseases. During this event, we launched the DNDi strategic plan to our regional partners.
- Prof. Samuel Kariuki, Ag Director General, KEMRI
Strengthening capacity for African-led research and innovation for new NTD tools
- Dr Margaret Agama –Anyetei, Ag Director for Health and Humanitarian Affairs, Africa Union Commission
The African continental framework on NTDs: its role in the control and elimination of NTDs in the next decade
- Dr Michael Makanga, Executive Director of the EDCTP Association Secretariat
Financing NTDs in the next decade
- Dr Monique Wasunna, Director DNDi Africa Regional Office
DNDi Strategic Plan 2021 – 2023 and its implications in Africa
- Gerald Chirinda, Founder, Youth Combating NTDs
Role of the youth in the control of NTDs in Africa
Moderated by: Dr Mercy Korir, Editor, Health & Science at The Standard Group LTD
If you have any questions, please contact us through email@example.com.